GU D116 Advanced Pharmacology Objective
W
Assessment OA & Final Exam Official Practice
Exam Actual Exam 2026/2027 with Detailed
Rationales | Complete Exam-Style Questions |
Pass Guaranteed – A+ Graded
═════════════════════════════════════
═
SECTION 1: PHARMACOKINETICS & PHARMACODYNAMICS Q1 – Q10
══════════════════════════════════════
Question 1 of 50
54-year-old male with atrial fibrillation is taking rivaroxaban. He is prescribed ritonavir-boosted
A
nirmatrelmov for a COVID-19 infection. The NP recognizes this combination significantly
increases the risk of bleeding due to the inhibition of which pharmacokinetic process?
. First-pass hepatic metabolism ✓ CORRECT
A
B. Renal tubular secretion
C. Plasma protein binding displacement
D. Gastrointestinal absorption
orrect Answer: A
C
Rationale: Ritonavir is a strong CYP3A4 and P-glycoprotein inhibitor that drastically reduces the
hepatic and intestinal first-pass metabolism of rivaroxaban, leading to increased systemic
exposure and bleeding risk. While ritonavir affects transporters, the primary mechanism for this
severe interaction is the inhibition of CYP3A4-mediated first-pass metabolism. Memorize major
CYP3A4 inhibitors like ritonavir, as they frequently require dose adjustments of narrow
therapeutic index drugs.
Question 2 of 50
62-year-old female with breast cancer on tamoxifen reports severe hot flashes and requests a
A
medication to help her sleep. The NP avoids prescribing paroxetine because it reduces the
efficacy of tamoxifen through the inhibition of which specific pharmacogenomic pathway?
. CYP2D6 ultra-rapid metabolism
A
B. CYP2D6 inhibition ✓ CORRECT
C. CYP3A4 inhibition
,D. CYP1A2 induction
orrect Answer: B
C
Rationale: Tamoxifen is a prodrug that requires conversion to its active metabolite, endoxifen, by
the CYP2D6 enzyme, and paroxetine is a potent CYP2D6 inhibitor that blocks this conversion.
CYP3A4 inhibition would actually increase tamoxifen levels, not decrease its efficacy, making it
an incorrect choice. Always avoid strong CYP2D6 inhibitors like SSRIs (paroxetine, fluoxetine)
in patients taking tamoxifen; use venlafaxine instead.
Question 3 of 50
45-year-old male with generalized anxiety disorder is prescribed buspirone after failing an
A
SSRI. The NP explains that buspirone's delayed onset of action is primarily due to its
classification as a partial agonist at which receptor?
. Dopamine D2 receptor
A
B. Alpha-1 adrenergic receptor
C. Serotonin 5-HT1A receptor ✓ CORRECT
D. Histamine H1 receptor
orrect Answer: C
C
Rationale: Buspirone acts as a partial agonist at serotonin 5-HT1A receptors, which requires
downstream neuronal adaptations over several weeks to produce anxiolytic effects, unlike
benzodiazepines which provide immediate relief. Dopamine D2 antagonism is a feature of
antipsychotics, not the primary mechanism of buspirone. Do not confuse buspirone's onset with
benzodiazepines; it takes 1-2 weeks to work and has no sedative properties.
Question 4 of 50
38-year-old male with epilepsy is started on phenytoin. Labs show a serum albumin of 2.2
A
g/dL. When interpreting the phenytoin level, the NP must account for the decreased protein
binding by calculating the corrected level, as phenytoin is highly bound to which plasma protein?
. Alpha-1 acid glycoprotein
A
B. Lipoproteins
C. Globulins
D. Albumin ✓ CORRECT
orrect Answer: D
C
Rationale: Phenytoin is highly protein-bound to albumin, meaning hypoalbuminemia results in a
higher fraction of free drug, making total phenytoin levels appear falsely low. Alpha-1 acid
glycoprotein primarily binds basic drugs like lidocaine, not acidic drugs like phenytoin. Use the
Sheiner-Tozer equation to correct phenytoin levels in patients with low albumin to avoid toxic
dosing.
, Question 5 of 50
70-year-old male taking warfarin for a mechanical mitral valve is diagnosed with a UTI and
A
prescribed trimethoprim-sulfamethoxazole. The NP anticipates that this antibiotic will rapidly
increase the INR primarily by displacing warfarin from its binding sites and inhibiting its
metabolism through which mechanism?
. CYP2C9 inhibition ✓ CORRECT
A
B. CYP3A4 induction
C. P-glycoprotein induction
D. Vitamin K antagonism
orrect Answer: A
C
Rationale: Sulfamethoxazole is a strong CYP2C9 inhibitor and displaces warfarin from
protein-binding sites, both of which dramatically increase the anticoagulant effect and INR. The
antibiotic does not act as a vitamin K antagonist, which is the mechanism of warfarin itself. Any
systemic antibiotic can alter gut flora that produces vitamin K, but CYP2C9 inhibition is the
primary rapid driver of this specific interaction.
Question 6 of 50
55-year-old male with acute decompensated heart failure and severe pulmonary edema
A
receives an intravenous bolus of furosemide. The NP understands that the large volume of
distribution in this patient will likely require a higher dose because the drug's distribution is
primarily confined to which compartment?
. Central nervous system
A
B. Extracellular fluid ✓ CORRECT
C. Intracellular fluid
D. Adipose tissue
orrect Answer: B
C
Rationale: Furosemide is a highly protein-bound, hydrophilic drug that distributes primarily into
the extracellular fluid, requiring higher doses in patients with edema to achieve effective
concentrations at the proximal tubule. Adipose tissue is the primary distribution site for lipophilic
drugs like benzodiazepines, not loop diuretics. In volume-overloaded states, the "third-spacing"
of hydrophilic drugs dilutes their concentration at the site of action.
Question 7 of 50
48-year-old female starts levothyroxine for hypothyroidism. She asks why she must take it
A
daily even though her TSH takes weeks to normalize. The NP explains that the need for daily
W
Assessment OA & Final Exam Official Practice
Exam Actual Exam 2026/2027 with Detailed
Rationales | Complete Exam-Style Questions |
Pass Guaranteed – A+ Graded
═════════════════════════════════════
═
SECTION 1: PHARMACOKINETICS & PHARMACODYNAMICS Q1 – Q10
══════════════════════════════════════
Question 1 of 50
54-year-old male with atrial fibrillation is taking rivaroxaban. He is prescribed ritonavir-boosted
A
nirmatrelmov for a COVID-19 infection. The NP recognizes this combination significantly
increases the risk of bleeding due to the inhibition of which pharmacokinetic process?
. First-pass hepatic metabolism ✓ CORRECT
A
B. Renal tubular secretion
C. Plasma protein binding displacement
D. Gastrointestinal absorption
orrect Answer: A
C
Rationale: Ritonavir is a strong CYP3A4 and P-glycoprotein inhibitor that drastically reduces the
hepatic and intestinal first-pass metabolism of rivaroxaban, leading to increased systemic
exposure and bleeding risk. While ritonavir affects transporters, the primary mechanism for this
severe interaction is the inhibition of CYP3A4-mediated first-pass metabolism. Memorize major
CYP3A4 inhibitors like ritonavir, as they frequently require dose adjustments of narrow
therapeutic index drugs.
Question 2 of 50
62-year-old female with breast cancer on tamoxifen reports severe hot flashes and requests a
A
medication to help her sleep. The NP avoids prescribing paroxetine because it reduces the
efficacy of tamoxifen through the inhibition of which specific pharmacogenomic pathway?
. CYP2D6 ultra-rapid metabolism
A
B. CYP2D6 inhibition ✓ CORRECT
C. CYP3A4 inhibition
,D. CYP1A2 induction
orrect Answer: B
C
Rationale: Tamoxifen is a prodrug that requires conversion to its active metabolite, endoxifen, by
the CYP2D6 enzyme, and paroxetine is a potent CYP2D6 inhibitor that blocks this conversion.
CYP3A4 inhibition would actually increase tamoxifen levels, not decrease its efficacy, making it
an incorrect choice. Always avoid strong CYP2D6 inhibitors like SSRIs (paroxetine, fluoxetine)
in patients taking tamoxifen; use venlafaxine instead.
Question 3 of 50
45-year-old male with generalized anxiety disorder is prescribed buspirone after failing an
A
SSRI. The NP explains that buspirone's delayed onset of action is primarily due to its
classification as a partial agonist at which receptor?
. Dopamine D2 receptor
A
B. Alpha-1 adrenergic receptor
C. Serotonin 5-HT1A receptor ✓ CORRECT
D. Histamine H1 receptor
orrect Answer: C
C
Rationale: Buspirone acts as a partial agonist at serotonin 5-HT1A receptors, which requires
downstream neuronal adaptations over several weeks to produce anxiolytic effects, unlike
benzodiazepines which provide immediate relief. Dopamine D2 antagonism is a feature of
antipsychotics, not the primary mechanism of buspirone. Do not confuse buspirone's onset with
benzodiazepines; it takes 1-2 weeks to work and has no sedative properties.
Question 4 of 50
38-year-old male with epilepsy is started on phenytoin. Labs show a serum albumin of 2.2
A
g/dL. When interpreting the phenytoin level, the NP must account for the decreased protein
binding by calculating the corrected level, as phenytoin is highly bound to which plasma protein?
. Alpha-1 acid glycoprotein
A
B. Lipoproteins
C. Globulins
D. Albumin ✓ CORRECT
orrect Answer: D
C
Rationale: Phenytoin is highly protein-bound to albumin, meaning hypoalbuminemia results in a
higher fraction of free drug, making total phenytoin levels appear falsely low. Alpha-1 acid
glycoprotein primarily binds basic drugs like lidocaine, not acidic drugs like phenytoin. Use the
Sheiner-Tozer equation to correct phenytoin levels in patients with low albumin to avoid toxic
dosing.
, Question 5 of 50
70-year-old male taking warfarin for a mechanical mitral valve is diagnosed with a UTI and
A
prescribed trimethoprim-sulfamethoxazole. The NP anticipates that this antibiotic will rapidly
increase the INR primarily by displacing warfarin from its binding sites and inhibiting its
metabolism through which mechanism?
. CYP2C9 inhibition ✓ CORRECT
A
B. CYP3A4 induction
C. P-glycoprotein induction
D. Vitamin K antagonism
orrect Answer: A
C
Rationale: Sulfamethoxazole is a strong CYP2C9 inhibitor and displaces warfarin from
protein-binding sites, both of which dramatically increase the anticoagulant effect and INR. The
antibiotic does not act as a vitamin K antagonist, which is the mechanism of warfarin itself. Any
systemic antibiotic can alter gut flora that produces vitamin K, but CYP2C9 inhibition is the
primary rapid driver of this specific interaction.
Question 6 of 50
55-year-old male with acute decompensated heart failure and severe pulmonary edema
A
receives an intravenous bolus of furosemide. The NP understands that the large volume of
distribution in this patient will likely require a higher dose because the drug's distribution is
primarily confined to which compartment?
. Central nervous system
A
B. Extracellular fluid ✓ CORRECT
C. Intracellular fluid
D. Adipose tissue
orrect Answer: B
C
Rationale: Furosemide is a highly protein-bound, hydrophilic drug that distributes primarily into
the extracellular fluid, requiring higher doses in patients with edema to achieve effective
concentrations at the proximal tubule. Adipose tissue is the primary distribution site for lipophilic
drugs like benzodiazepines, not loop diuretics. In volume-overloaded states, the "third-spacing"
of hydrophilic drugs dilutes their concentration at the site of action.
Question 7 of 50
48-year-old female starts levothyroxine for hypothyroidism. She asks why she must take it
A
daily even though her TSH takes weeks to normalize. The NP explains that the need for daily
